Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Live Attenuated Mumps Vaccine in Healthy Infants
NCT05065177Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Jan 2016
- Primary completion
- Mar 2016
- Modality
- Live Attenuated Vaccines, Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of mumps vaccine, live in mumps, sponsored by Sinovac Biotech Ltd.. Started Jan 2016; status: completed.
02
Drugs
mumps vaccine, live
03
Conditions
mumps
Beyond the preview
Go deeper on NCT05065177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05065177.